Concepedia

Jiming Shen

JS

Statistics

Publications

4

Citations

125

H-Index

4

Active since

2019

Affiliations

China Medical University(Current)

First Hospital of China Medical University

Jiming Shen is an author at China Medical University specializing in oncology, molecular oncology, and medicine.

Publications per year

2019–2021

4

Publications

4

Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance

Jing Feng, Ti Wen, Zhi Li et al. · Aging · 2020 · 46 citations · Full text

, , +17

Genome-Wide Identification of a Novel Eight-lncRNA Signature to Improve Prognostic Prediction in Head and Neck Squamous Cell Carcinoma

Bowen Yang, Jiming Shen, Lu Xu et al. · Frontiers in Oncology · 2019 · 43 citations · Full text

, , +17

FEN1 is a prognostic biomarker for ER+ breast cancer and associated with tamoxifen resistance through the ERα/cyclin D1/Rb axis

Lu Xu, Jiming Shen, Jinglei Qu et al. · Annals of Translational Medicine · 2021 · 24 citations · Full text

, , +16

A bibliometric analysis of researches on flap endonuclease 1 from 2005 to 2019

Qiaochu Wei, Jiming Shen, Dongni Wang et al. · BMC Cancer · 2021 · 12 citations · Full text

, , +11

1–4 of 4